Literature DB >> 18268406

Sustained response to low-dose imatinib mesylate in a patient with chronic myelomonocytic leukemia with t(5;12)(q33;p13).

Juyoung Shin1, Myungshin Kim, Dae-Bum Kim, Ju-Ok Yeom, Hyo-Jin Lee, Seok-Goo Cho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18268406     DOI： 10.1159/000115966

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  2 in total

1.  Successful treatment with low-dose imatinib mesylate of therapy-related myeloid neoplasm harboring TEL-PDGFRB in a patient with acute promyelocytic leukemia.

Authors:  Norio Asou; Eisaku Iwanaga; Tomoko Nanri; Hiroaki Mitsuya
Journal:  Haematologica       Date:  2010-09       Impact factor: 9.941

2.  Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes.

Authors:  Hung Chang; Wen-Yu Chuang; Chien-Feng Sun; Marc R Barnard
Journal:  Diagn Pathol       Date:  2012-02-22       Impact factor: 2.644
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.